Translational Cancer Research Impact Factor 2025-26

Translational Cancer Research Impact Factor

Translational Cancer Research (TCR) is a scholarly journal dedicated to publishing research in the field of Medicine, and Published by AME Publishing Company. The Print-ISSN of Translational Cancer Research is 2218-676X and its abbreviation is Transl Cancer Res.

The latest Impact Factor of the Translational Cancer Research for 2025-2026 is 0.9.


Translational Cancer Research Impact Factor List

The impact factor or journal impact factor of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science.

Sr.no Year Journal Impact Factor (JIF)

To know more about Translational Cancer Research visit click here


F T L W E